Table 1. exRNA factor structured in Framingham Heart Study cohort (N=2,763).
Rate expressed | Cq | Targets* | Unique targets* | ||
---|---|---|---|---|---|
N | Mean±s.d. (range) | Mean±s.d. (range) | (N) | (N) | |
miRNA | |||||
F1 | 108 | 49.4±22.3 (11.9, 93.5) | 19.2±1.5 (9.7, 20.9) | 23,240 | 3,205 |
F2 | 67 | 4.4±2.0 (1.1, 8.4) | 20.3±0.6 (16.8, 20.9) | 18,898 | 2,718 |
F3 | 40 | 94.8±2.9 (84.2, 98.3) | 17.9±1.6 (11.9, 19.9) | 15,487 | 645 |
F4 | 17 | 68.6±21.9 (22.7, 94.3) | 19.9±0.6 (18.8, 20.9) | 13,928 | 156 |
None | 100 | 34.2±24.0 (1.4, 95.3) | 20.4±0.6 (17.3, 21,2) | ||
piRNA | |||||
F1 | 17 | 53.2±22.4 (11.5, 90.8) | 20.0±0.5 (19.1, 20.9) | ||
F2 | 14 | 0.3±0.1 (0.1, 0.5) | 18.0±2.4 (13.3, 20.6) | ||
F3 | 12 | 4.0±3.0 (1.4, 11.1) | 20.6±3.2 (20.1, 21.1) | ||
F4 | 7 | 51.9±20.1 (22.1, 77.3) | 20.3±0.4 (19.6, 20.7) | ||
None | 47 | 18.9±29.2 (0.4, 99.6) | 20.4±1.3 (16.0, 21.3) | ||
snoRNA | |||||
F1 | 13 | 4.6±2.0 (2.0, 8.3) | 20.0±0.5 (19.0, 20.7) | ||
F2 | 9 | 29.3±18.4 (13.3, 65.9) | 20.3±0.7 (18.6, 20.8) | ||
F3 | 8 | 67.8±22.9 (43.6, 95.0) | 19.6±0.9 (18.3, 20.4) | ||
F4 | 6 | 17.3±9.0 (8.8, 30.6) | 20.4±0.1 (20.2, 20.6) | ||
None | 7 | 41.1±32.2 (9.6, 92.7) | 20.3±0.7 (19.4, 20.9) |
*miRDB Version 5.0 target predictions available at (http://mirdb.org/miRDB/download.html).